Bellerophon Therapeutics, Inc. (BLPH) stock declined in the Pre-Market today, here is why?
The stock of Bellerophon Therapeutics, Inc. (BLPH) declined slightly in the pre-market following the news of its update on the phase 2 trials of INOpulse. The stock of the company was valued at $2.69 in the pre-market. This is a loss of more than 15.67% from the previously closed value. At the end of the […]
